Guggul Extract 10% Guggulsterones/2.5% E & Z

CSV Pharmaceuticals Pvt. Ltd. supplies a Guggul Extract that contains 10 % Guggulsterones and 2.5 % of the E & Z isomers. The extract is obtained from the resin of the Commiphora mukul tree native to India. It is offered in both fine powder and pre‑filled capsule formats to suit different manufacturing lines. The product is marketed for industrial‑grade use in the nutraceutical sector.

In the herbal extract market, a typical assay tolerance for Guggulsterones is ±0.5 %. Standard moisture content for dried extracts is usually below 5 % to ensure stability. Residual solvent limits are commonly set at less than 10 ppm according to pharmacopeial guidelines. Quality control generally relies on HPLC analysis, a standard method for quantifying guggulsterone levels.

The extract is widely incorporated into dietary supplements aimed at weight management, cholesterol regulation, and metabolic support. Primary buyers include supplement manufacturers and functional‑food producers seeking a botanical active. Trade terms stated by the supplier include flexible minimum order quantities and shipment under FOB or CIF incoterms, with payment possible by L/C or T/T.

CSV Pharmaceuticals Pvt. Ltd. is an imported supplier based in India. The listing shows a harbor trust tier, indicating a moderate level of verification on the platform. The supplier’s response metrics currently show a 0 % response rate with no recorded response time, suggesting a need for direct contact to assess communication reliability. The company’s profile does not disclose additional corporate history or production capacity.

The product listing focuses on the Guggul Extract and does not provide details on certifications, manufacturing facilities, or quality management systems beyond the mention of ISO and SGS in the description, which the buyer should verify independently. CSV Pharmaceuticals offers the extract in bulk quantities suitable for B2B transactions. Prospective buyers are encouraged to request sample analysis reports and any relevant compliance documentation before finalising an order.